Swati Singh

Title: Swati Singh: Innovator in Gene Regulation

Introduction

Swati Singh is a prominent inventor based in Seattle, WA, known for her contributions to the field of gene regulation. She has made significant strides in the incorporation of FOXP3 cDNA into edited CD34+ cells, which has implications for gene therapy and cellular engineering.

Latest Patents

Swati Singh holds a patent for the "Expression of FOXP3 in edited CD34+ cells." This invention focuses on the incorporation of a FOXP3 cDNA into a FOXP3 gene or a non-FOXP3 locus, enabling either constitutive or regulated FOXP3 expression in primary human CD34+ cells or cells derived from edited CD34+ cells. The patent also discusses the use of guide RNA sequences for CRISPR/Cas9-mediated gene regulation and gene delivery cassettes for HDR-based gene modification. She has 1 patent to her name.

Career Highlights

Swati Singh is affiliated with Seattle Children's Hospital, where she continues her research and innovation in gene therapy. Her work is pivotal in advancing the understanding of gene regulation and its applications in medicine.

Collaborations

Swati collaborates with esteemed colleagues, including David J Rawlings and Iram F Khan, who contribute to her research endeavors and enhance the impact of her work in the scientific community.

Conclusion

Swati Singh's innovative work in gene regulation exemplifies the potential of genetic engineering in medicine. Her contributions are paving the way for future advancements in therapeutic applications.